GLP-1 receptors exist in the area postrema of the brainstem, the region that controls the vomit reflex
Adjusting Dosage Switching medications involves a titration period to ensure your body adjusts to Semaglutide
But weve previously highlighted how 2026 is a big year for GLP-1 drugs because semaglutide, the active ingredient in Ozempic and Wegovy, comes off-patent in India, China, Canada and Brazil this year
So, you know, I think it's possible
At this dose, appetite suppression is typically strong and consistent
Peoples perceptions of weight and obesity likely play a strong role, too